Speaker Profile
Ph.D., MBA, CEO, CREATE Medicines
Biography
Daniel Getts is a global leader in RNA therapeutics and immune engineering. An Australian-born, US-naturalized scientist and entrepreneur, he is the founder and CEO of multiple biotech ventures, including CREATE Medicines, a clinical-stage company focused on in vivo mRNA immune cell programming, and Aurora Biosynthetics, Australia’s first GMP RNA manufacturing facility, developed in partnership with the NSW Government to strengthen regional biotechnology capability.
Throughout his career, Getts has founded or co-founded several biotechnology companies, including Cour Pharmaceuticals, the field leader in immune tolerance, striking major partnerships with Takeda ($420M) and Genentech ($940M). Collectively, his ventures have generated more than $2 billion USD in value and advanced 11 novel therapies into clinical trials across cancer, autoimmune disease, and transplant rejection.
Getts earned his PhD in Medicine from the University of Sydney and his MBA from Western Michigan University. He conducted postdoctoral research at Northwestern University, where he co-invented multiple immune modulation platforms.
Talk
TBD
TBD
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
